Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
- PMID: 18226441
- DOI: 10.1016/j.eururo.2007.12.034
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
Abstract
Objectives: To assess the accuracy of magnetic resonance (MR) spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced MR (DCEMR) in the depiction of local prostate cancer recurrence in patients with biochemical progression after radical prostatectomy (RP).
Materials and methods: 1H-MRSI and DCEMR were performed in 70 patients at high risk of local recurrence after RP. The population was divided on the basis of the clinical validation of MR results with the use of a transrectal ultrasound biopsy examination in a group of 50 patients (group A) and the prostate-specific antigen (PSA) serum level restitution after external beam radiotherapy, in a group of 20 patients (group B).
Results: In group A, 1H-MRSI analysis alone showed a sensitivity of 84% and a specificity of 88%; the DCEMR analysis alone, a sensitivity of 71% and a specificity of 94%; combined 1HMRSI-DCEMR, a sensitivity of 87% and specificity of 94%. Areas under the receiver operating characteristic (ROC) curve for 1HMRSI, DCEMR, and combined 1HMRSI /DCEMR were 0.942, 0.93,1 and 0.964, respectively. In group B, 1HMRSI alone showed a sensitivity of 71% and a specificity of 83%; DCEMR, a sensitivity of 79% and a specificity of 100%; combined 1HMRSI and DCEMR, a sensitivity of 86% and a specificity of 100%. Areas under the ROC curve for each of these groups were 0.81, 0.923, and 0.94, respectively.
Conclusion: Our results show that combined 1H-MRSI and DCMRE is an accurate method to identify local prostate cancer recurrence in patients with biochemical progression after RP.
Comment in
-
Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.Eur Urol. 2008 Sep;54(3):599-600. doi: 10.1016/j.eururo.2007.12.036. Epub 2007 Dec 31. Eur Urol. 2008. PMID: 18226439 No abstract available.
-
Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.Eur Urol. 2008 Sep;54(3):598-9. doi: 10.1016/j.eururo.2007.12.035. Epub 2007 Dec 31. Eur Urol. 2008. PMID: 18226440 No abstract available.
-
Re: Alessandro Sciarra, Valeria Panebianco, Stefano Salciccia, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589-600.Eur Urol. 2009 Jan;55(1):e2-3; author reply e4-5. doi: 10.1016/j.eururo.2008.06.029. Epub 2008 Jun 13. Eur Urol. 2009. PMID: 18572302 No abstract available.
-
Words of wisdom. Re: Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?Eur Urol. 2009 Feb;55(2):524-5. doi: 10.1016/j.eururo.2008.11.017. Eur Urol. 2009. PMID: 19606536 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
